Patanjali Ayurved has had a meteoric rise since its birth five years ago. The big players in the FMCG sector like Unilever, Proctor & Gamble, are already feeling the heat.
The Baba Ramdev Corporation has a turnover of Rs 1587 crore in 2015, a 100% jump as compared to 2014. Compare this with companies like Dabur which after decades of existence are raking in Rs 4233 crores. Patanjali is aiming for a turnover of more than Rs 7000 crores.
Founder godman Ramdev quips that his firm is diversifying in every zone. His business group has taken the might of global health drinks, sports apparels, and is already the biggest spender in FMCG advertising spending.
The five-year-old company has launched an app for the health consultation, and it could upset the fortunes of other biggies in the field who are taking their first tentative steps in this market segment and are banking on investor’s money to increase their reach.
Check all the Patanjali products here.
Executives from the Uttarakhand-based conglomerate have revealed that more than Rupees 1000 crores will be spent on widening the scope and the volume of the new online healthcare startup.
With clockwork precision and ruthless efficiency, the policy makers of the Uttarakhand-based firm is taking on the big Whigs of the industry and the latest to feature on its cross hairs is GlaxoSmithKline Consumer Healthcare, another world significant in food supplement category.
Already GSK Consumer, the maker of Horlicks has a disappointing January –March 2016 quarter and experts are expressing concerns if Glaxo has the capability take on Baba Ram Dev’s Ayurvedic firm which has just launched Powervita brand.
However, experts doubt if Patanjali Ayurveda can capture a significant share in HFD segment. The Ayurvedic company entered categories like Chawanprash, honey and toothpaste by offering discounts. However, it is not offering much discount when it comes to the food supplement segment.